Thompson Davis & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,150	Closed	-$241K	–	149
2021 Q4	$241K	Buy	+2,150	New	+$259K	0.2%	87
2018 Q3	$380K	Buy	3,960 +625	+19%	+$60.6K	0.83%	26
2018 Q2	$317K	Hold	3,335	–	–	0.75%	34
2018 Q1	$293K	Buy	3,335 +85	+3%	+$7.76K	0.77%	32
2017 Q4	$276K	Sell	3,250 -2,002	-38%	-$168K	0.65%	31
2017 Q3	$455K	Buy	5,252 +1,126	+27%	+$90.3K	0.81%	20
2017 Q2	$318K	Buy	4,126 +1,876	+83%	+$133K	0.51%	49
2017 Q1	$156K	Buy	2,250 +2,000	+800%	+$134K	0.22%	96
2016 Q4	$15K	Hold	250	–	–	0.02%	598
2016 Q3	$17K	Hold	250	–	–	0.03%	533
2016 Q2	$14K	Buy	250 +125	+100%	+$6.85K	0.02%	569
2016 Q1	$6K	Sell	125 -500	-80%	-$26K	0.01%	760
2015 Q4	$44K	Buy	+625	New	+$42.6K	0.06%	283